Outcomes in Real-life after Initation of treatment with Trixeo (Budesonide / Glycopyrronium / Formoterol) - CHOROS ORION

Study identifier:D5980R00076

ClinicalTrials.gov identifier:NCT05862545

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

Outcomes in Real-life after Initation Of treatmeNt with Trixeo (Budesonide / Glycopyrronium / Formoterol), a non-interventional, multi-centre, prospective cohort study in Italian routine care setting

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

N/A

Healthy volunteers

No

Study drug

BGF (budesonide/glycopyrrolate/formoterol fumarate)

Sex

All

Actual Enrollment

250

Study type

Observational

Age

40 Years - 120 Years

Date

Study Start Date: 01 Jun 2023
Estimated Primary Completion Date: 28 Jul 2025
Estimated Study Completion Date: 28 Jul 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria